Opinion: The rare pediatric disease voucher program creates new treatments. I have new data to prove it
STAT
JULY 2, 2024
The Food and Drug Administration’s rare pediatric disease priority review voucher program , which has been providing incentives for lifesaving innovations since 2012, is doomed to disappear unless Congress reauthorizes it before the end of September. I have data showing it works. None worked. Read the rest…
Let's personalize your content